Breast Cancer Screening Gets Personal | DOTmed

Posted by Navid Alipour, Chief Executive Officer on Jul 7, 2021 10:33:35 AM

Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News.  cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.

Read More

Topics: News, AI, mammogram, cmTriage, cmAssist, AI Mammogram, CHD, heart disease, cmangio